BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 76 filers reported holding BIOLIFE SOLUTIONS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,190,000 | -50.3% | 58,761 | -43.5% | 0.19% | -51.3% |
Q3 2021 | $4,403,000 | -55.6% | 104,032 | -53.3% | 0.39% | -49.7% |
Q2 2021 | $9,922,000 | +49.7% | 222,922 | +21.1% | 0.78% | +36.9% |
Q1 2021 | $6,629,000 | -23.9% | 184,142 | -15.7% | 0.57% | -44.5% |
Q4 2020 | $8,714,000 | +37.8% | 218,452 | 0.0% | 1.02% | +60.5% |
Q3 2020 | $6,322,000 | +89.1% | 218,452 | +6.9% | 0.64% | +99.7% |
Q2 2020 | $3,343,000 | -15.6% | 204,440 | -51.0% | 0.32% | -42.0% |
Q1 2020 | $3,960,000 | -56.9% | 416,890 | -26.6% | 0.55% | -48.0% |
Q4 2019 | $9,186,000 | -12.0% | 567,768 | -9.6% | 1.05% | +15.3% |
Q3 2019 | $10,437,000 | -29.0% | 627,768 | -27.7% | 0.91% | -7.0% |
Q2 2019 | $14,709,000 | -15.1% | 867,768 | -10.4% | 0.98% | -27.1% |
Q1 2019 | $17,319,000 | +48.7% | 968,073 | 0.0% | 1.35% | +36.6% |
Q4 2018 | $11,645,000 | -15.1% | 968,073 | +23.5% | 0.99% | +42.4% |
Q3 2018 | $13,717,000 | +696.1% | 783,820 | +418.9% | 0.69% | +381.2% |
Q2 2018 | $1,723,000 | – | 151,040 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |